Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Colorectal Neoplasms

Free Subscription Articles published in Br J Surg Retrieve available abstracts of 194 articles: HTML format

Single Articles

May 2024
1. ZAFFARONI G, Mannucci A, Koskenvuo L, de Lacy B, et al
   Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EH
   Br J Surg. 2024;111:znae070.
   PubMed     Abstract available
   
   
   
2. OLTHOF K, Smit J, Fusaglia M, Kok N, et al
   A surgical navigation system to aid the ablation of vanished colorectal liver metastases.
   Br J Surg. 2024;111:znae110.
   PubMed    
   
   
   April 2024
3. KRUL MF, Kok NFM, Osmani H, Buisman FE, et al
   Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
   Br J Surg. 2024;111:znae089.
   PubMed     Abstract available
   
   
   March 2024
4. CUK P, Tiskus M, Moller S, Lambertsen KL, et al
   Surgical stress response in robot-assisted versus laparoscopic surgery for colon cancer (SIRIRALS): randomized clinical trial.
   Br J Surg. 2024;111:znae049.
   PubMed     Abstract available
   
   
   
5. GLYNNE-JONES R, Harrison M
   Colorectal cancer para-aortic lymph node metastases: surgery should not be considered.
   Br J Surg. 2024;111:znad443.
   PubMed    
   
   
   
6. PEACOCK O
   Colorectal cancer para-aortic lymph node metastases-surgery should be considered.
   Br J Surg. 2024;111:znad445.
   PubMed    
   
   
   
7. PEREA J, Garcia JL, Corchete LA, Marti M, et al
   Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers.
   Br J Surg. 2024;111:znae041.
   PubMed    
   
   
   
8. MARTIN-CULLELL B, Virgili AC, Riera P, Fumagalli C, et al
   Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases.
   Br J Surg. 2024;111:znae016.
   PubMed     Abstract available
   
   
   January 2024
9. GOMEZ RUIZ M, Espin-Basany E, Spinelli A, Cagigas Fernandez C, et al
   Author response to: Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST).
   Br J Surg. 2024;111:znad444.
   PubMed    
   
   
   
10. KELM M, Flemming S
    Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis Study (MIRCAST).
    Br J Surg. 2024;111:znad440.
    PubMed    
    
    
    
11. ALISEDA D, Arredondo J, Sanchez-Justicia C, Alvarellos A, et al
    Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis.
    Br J Surg. 2024;111:znae021.
    PubMed     Abstract available
    
    
    
12. BROWN KGM, Solomon MJ, Sutton PA, Shin JS, et al
    The definition of clear resection margins in locally recurrent rectal cancer-time for consensus.
    Br J Surg. 2024;111:znad450.
    PubMed    
    
    
    
13. KRON P, Lodge JPA
    Changing perspectives in the treatment of colorectal liver metastases.
    Br J Surg. 2024;111:znad431.
    PubMed    
    
    
    
14. KUSTERS M
    Lateral pelvic lymph nodes in rectal cancer: a multi-disciplinary team effort is needed to prevent local recurrence.
    Br J Surg. 2024;111:znad449.
    PubMed    
    
    
    
15. TAYLOR AS, Au S, Krivankova B, Asanai K, et al
    Carbon footprint of laparoscopic right hemicolectomy.
    Br J Surg. 2024;111:znad422.
    PubMed    
    
    
    
16. SANO S, Fukunaga Y, Sakamoto T, Hiyoshi Y, et al
    Laparoscopic resection for locally advanced rectal cancer: propensity score-matched analysis.
    Br J Surg. 2024;111:znad350.
    PubMed    
    
    
    
17. AUSTIN KKS, Brown KGM, Solomon MJ
    En bloc lateral pelvic compartment excision during pelvic exenteration: video vignette.
    Br J Surg. 2024;111:znad407.
    PubMed    
    
    
    
18. DELATTRE F, Trilling B, Sage PY, Bonne A, et al
    Complete mesocolic excision for caecal tumours is overtreatment: COLOC study.
    Br J Surg. 2024;111:znad411.
    PubMed    
    
    
    
19. SADIEN ID
    Comment on: Non-invasive measurement of intestinal tissue oxygen saturation for evaluation of reconstructed blood flow in rectal cancer surgery: HiSCO-09 study.
    Br J Surg. 2024;111:znad399.
    PubMed    
    
    
    
20. SHIMOMURA M, Yoshinaka H, Egi H, Shimizu W, et al
    Author response to: Comment on: Non-invasive measurement of intestinal tissue oxygen saturation for evaluation of reconstructed blood flow in rectal cancer surgery: HiSCO-09 study.
    Br J Surg. 2024;111:znad400.
    PubMed    
    
    
    
21. WU Q, He Y, Wang Z
    Author response: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Br J Surg. 2024;111:znad390.
    PubMed    
    
    
    
22. ZHANG W, Huang J
    Comment on: Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Br J Surg. 2024;111:znad389.
    PubMed    
    
    
    
23. BRAUN M
    T3N1M0 rectal cancer: the optimal initial management is systemic anti-cancer therapy.
    Br J Surg. 2024;111:znad324.
    PubMed    
    
    
    
24. NILSSON PJ
    T3 N1 M0 rectal cancer: optimal initial management is total neoadjuvant therapy.
    Br J Surg. 2024;111:znad322.
    PubMed    
    
    
    
25. ARTHUR C, Teo M
    T3 N1 M0 rectal cancer: the optimal initial management is long-course chemoradiotherapy.
    Br J Surg. 2024;111:znad323.
    PubMed    
    
    
    
26. HARRIS DA
    T3 N1 M0 rectal cancer: optimal initial management is upfront surgery.
    Br J Surg. 2024;111:znad321.
    PubMed    
    
    
    
27. BONNE A, Trilling B, Sage PY, Fauconnier J, et al
    Influence of day of surgery on morbidity after laparoscopic colorectal resection for cancer in the era of enhanced recovery after surgery (ERAS).
    Br J Surg. 2024;111:znad387.
    PubMed    
    
    
    
28. STRIJKER D, Hoogeboom TJ, Meijerink JWJH, Taveirne A, et al
    Multimodal rehabilitation (Fit4Chemo) before and during adjuvant chemotherapy in patients with colonic cancer.
    Br J Surg. 2024;111:znad354.
    PubMed    
    
    
    
29. BILKHU AS, Wild J, Sagar PM
    Management of retrorectal tumours.
    Br J Surg. 2024;111:znae012.
    PubMed    
    
    
    December 2023
30. GRUTER AAJ, Toorenvliet BR, Belgers EHJ, Belt EJT, et al
    Nationwide standardization of minimally invasive right hemicolectomy for colon cancer and development and validation of a video-based competency assessment tool (the Right study).
    Br J Surg. 2023 Dec 16:znad404. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. LYGRE KB, Eide GE, Liedenbaum MH, Augland IMB, et al
    Short and equal vascular stump length after standardized laparoscopic and open surgery with central lymphadenectomy for right-sided colon cancer.
    Br J Surg. 2023 Dec 8:znad410. doi: 10.1093.
    PubMed    
    
    
    November 2023
32. MIZUUCHI Y, Nagayoshi K, Nakamura M, Ikeuchi H, et al
    Prognostic impact of tumour location in stage II/III ulcerative colitis-associated colon cancer: subgroup analysis of a nationwide multicentre retrospective study in Japan.
    Br J Surg. 2023 Nov 25:znad386. doi: 10.1093.
    PubMed    
    
    
    
33. LEDERHUBER H, Massey LH, Abeysiri S, Roman MA, et al
    Preoperative intravenous iron and the risk of blood transfusion in colorectal cancer surgery: meta-analysis of randomized clinical trials.
    Br J Surg. 2023 Nov 23:znad320. doi: 10.1093.
    PubMed    
    
    
    
34. ROTTOLI M, Spinelli A, Pellino G, Gori A, et al
    Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study.
    Br J Surg. 2023 Nov 14:znad373. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. ZHANG K, Yuan Z, Lu Y, Chen L, et al
    Totally robotic surgery for rectal cancer with the daVinci(R) single-port platform.
    Br J Surg. 2023;110:1890.
    PubMed    
    
    
    
36. GREIJDANUS NG, Wienholts K, Ubels S, Talboom K, et al
    Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients.
    Br J Surg. 2023;110:1863-1876.
    PubMed     Abstract available
    
    
    
37. YOSHINAKA H, Shimomura M, Egi H, Shimizu W, et al
    Non-invasive measurement of intestinal tissue oxygen saturation for evaluation of reconstructed blood flow in rectal cancer surgery: HiSCO-09 study.
    Br J Surg. 2023;110:1769-1773.
    PubMed    
    
    
    
38. VIMALACHANDRAN D
    Neoadjuvant chemotherapy for locally advanced colonic cancer is not ready to be the standard of care.
    Br J Surg. 2023;110:1677-1678.
    PubMed    
    
    
    
39. MORTON D, Seligmann J
    Neoadjuvant chemotherapy for locally advanced colonic cancer is the standard of care.
    Br J Surg. 2023;110:1679-1680.
    PubMed    
    
    
    
40. VAUGHAN-SHAW PG, Evans MD
    Neoadjuvant chemotherapy for advanced colonic cancer: standard of care or is the jury still out?
    Br J Surg. 2023;110:1565-1566.
    PubMed    
    
    
    
41. KIYOZUMI Y, Yamaguchi T, Ichikawa N, Homma S, et al
    Endoscopic Surgical Skill Qualification System: propensity-score matched cohort analysis of accredited supervisors in laparoscopic rectal cancer surgery.
    Br J Surg. 2023;110:1834-1839.
    PubMed     Abstract available
    
    
    
42. NORDKAMP S, van Rees JM, van den Berg K, Mens DM, et al
    Locally recurrent rectal cancer: oncological outcomes of neoadjuvant chemoradiotherapy with or without induction chemotherapy.
    Br J Surg. 2023;110:1637-1640.
    PubMed    
    
    
    
43. FRANCIS NK, Penna M, Dritsas S, Kinsey H, et al
    Oncological outcomes after transanal total mesorectal excision for rectal cancer.
    Br J Surg. 2023;110:1614-1617.
    PubMed    
    
    
    
44. GAO J, Gu X, Pang M, Zhang H, et al
    Risk factors for anastomotic leak and postoperative morbidity after right hemicolectomy for colon cancer: results from a prospective, multi-centre, snapshot study in China.
    Br J Surg. 2023 Nov 7:znad316. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
45. JONES RP, Lee LYW, Corrie PG, Danson S, et al
    Individualized cancer vaccines versus surveillance after adjuvant chemotherapy for surgically resected high-risk stage 2 and stage 3 colorectal cancer: protocol for a randomized trial.
    Br J Surg. 2023 Oct 19:znad332. doi: 10.1093.
    PubMed    
    
    
    
46. YANG X, Hu Q
    Comment on: Outcomes of laparoscopic versus robotic-assisted resection of T4 rectal cancer: propensity score-matched analysis of a national cancer database.
    Br J Surg. 2023;110:1562.
    PubMed    
    
    
    
47. VAN EERDEN RAG, de Boer NL, van Kooten JP, Bakkers C, et al
    Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.
    Br J Surg. 2023;110:1502-1510.
    PubMed     Abstract available
    
    
    September 2023
48. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Author response to: Comment on: Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:1407.
    PubMed    
    
    
    
49. HANY TS, Jadav AM, Parkin E, Bhowmick AK, et al
    Extraperitoneal approach to left-sided colorectal resections (EXPERTS procedure).
    Br J Surg. 2023;110:1348-1354.
    PubMed    
    
    
    
50. YANG X, Hu Q
    Comment on: Early outcomes from the Minimally Invasive Right Colectomy Anastomosis Study (MIRCAST).
    Br J Surg. 2023;110:1406.
    PubMed    
    
    
    
51. EMILE SH, Wexner SD
    Author response to: Comment on: Outcomes of laparoscopic versus robotic-assisted resection of T4 rectal cancer: propensity score-matched analysis of a national cancer database.
    Br J Surg. 2023;110:1405.
    PubMed    
    
    
    
52. JONES S, Perin G, Balasubramanian S
    Comment on: Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
    Br J Surg. 2023;110:1404.
    PubMed    
    
    
    
53. DONNELLY M, Ryan OK, Ryan EJ, Creavin B, et al
    Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Br J Surg. 2023;110:1316-1330.
    PubMed     Abstract available
    
    
    
54. VOIGT KR, Wullaert L, de Graaff MR, Verhoef C, et al
    Association between textbook outcome and long-term survival after surgery for colorectal liver metastases.
    Br J Surg. 2023;110:1284-1287.
    PubMed    
    
    
    
55. ARJONA-SANCHEZ A
    In favour of prophylactic hyperthermic intraperitoneal chemotherapy for colorectal cancer.
    Br J Surg. 2023 Sep 2:znad279. doi: 10.1093.
    PubMed    
    
    
    
56. TANIS PJ
    Opposed to prophylactic hyperthermic intraperitoneal chemotherapy for colorectal cancer.
    Br J Surg. 2023 Sep 2:znad280. doi: 10.1093.
    PubMed    
    
    
    August 2023
57. TEMMINK SJD, Peeters KCMJ, Renehan AG, Pares O, et al
    Author response to: Comment on: Outcomes following watch and wait of a clinical complete response in rectal cancer after neoadjuvant treatment: comparison of patients with and without complete response at first reassessment in the International Watch
    Br J Surg. 2023;110:1242.
    PubMed    
    
    
    
58. GOMEZ RUIZ M, Espin-Basany E, Spinelli A, Cagigas Fernandez C, et al
    Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST).
    Br J Surg. 2023;110:1153-1160.
    PubMed     Abstract available
    
    
    
59. MEURETTE G, Faucheron JL, Cotte E, Denost Q, et al
    Low anterior resection syndrome after rectal resection management: multicentre randomized clinical trial of transanal irrigation with a dedicated device (cone catheter) versus conservative bowel management.
    Br J Surg. 2023;110:1092-1095.
    PubMed    
    
    
    
60. VAN REES JM, Krul MF, Kok NFM, Grunhagen DJ, et al
    Treatment of locally advanced rectal cancer and synchronous liver metastases: multicentre comparison of two treatment strategies.
    Br J Surg. 2023;110:1049-1052.
    PubMed    
    
    
    July 2023
61. SHAH D, Di Re A, Toh JWT
    Aspirin chemoprevention in colorectal cancer: network meta-analysis of low, moderate, and high doses.
    Br J Surg. 2023 Jul 27:znad231. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. BEETS GL
    Near-complete response following neoadjuvant therapy in rectal cancer: wait a bit longer?
    Br J Surg. 2023;110:938-939.
    PubMed    
    
    
    
63. MANENTI A, Caramaschi S, Farinetti A, Manco G, et al
    Comment on: Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis.
    Br J Surg. 2023;110:1018.
    PubMed    
    
    
    
64. PEREZ RO, Cerdan-Santacruz C, Sao Juliao GP
    Near-complete response following neoadjuvant therapy in rectal cancer: resect now?
    Br J Surg. 2023;110:936-937.
    PubMed    
    
    
    
65. GE Y, Zhang S, Zheng M, Zhang W, et al
    Comment on: Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis.
    Br J Surg. 2023;110:1017.
    PubMed    
    
    
    
66. NORDKAMP S, Piqeur F, van den Berg K, Tolenaar JL, et al
    Locally recurrent rectal cancer: Oncological outcomes for patients with a pathological complete response after neoadjuvant therapy.
    Br J Surg. 2023;110:950-957.
    PubMed     Abstract available
    
    
    
67. PEACOCK O, Manisundaram N, Kim Y, Konishi T, et al
    Therapeutic lateral pelvic lymph node dissection in rectal cancer: when to dissect? Size is not everything.
    Br J Surg. 2023;110:985-986.
    PubMed    
    
    
    
68. UUTELA A, Nordin A, Osterlund E, Halonen P, et al
    Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study.
    Br J Surg. 2023;110:931-935.
    PubMed    
    
    
    
69. SIRIWARDENA AK, Serrablo A, Fretland AA, Wigmore SJ, et al
    Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.
    Br J Surg. 2023 Jul 14:znad124. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
70. KATAOKA K, Takahashi K, Takeuchi J, Ito K, et al
    Correlation between recurrence-free survival and overall survival after upfront surgery for resected colorectal liver metastases.
    Br J Surg. 2023;110:864-869.
    PubMed     Abstract available
    
    
    
71. WU Q, Zhou J, Huang J, Deng X, et al
    Total neoadjuvant therapy versus chemoradiotherapy for locally advanced rectal cancer: Bayesian network meta-analysis.
    Br J Surg. 2023;110:784-796.
    PubMed     Abstract available
    
    
    
72. VERWEIJ ME, Franzen J, van Grevenstein WMU, Verkooijen HM, et al
    Timing of rectal cancer surgery after short-course radiotherapy: national database study.
    Br J Surg. 2023;110:839-845.
    PubMed     Abstract available
    
    
    
73. GERRARD AD, Dunlop MG, Din FVN
    Author response to: Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Br J Surg. 2023 Jun 1:znad121. doi: 10.1093.
    PubMed    
    
    
    May 2023
74. COHEN R, Platell CF, McCoy MJ, Meehan K, et al
    Circulating tumour DNA in colorectal cancer management.
    Br J Surg. 2023 May 16:znad126. doi: 10.1093.
    PubMed    
    
    
    
75. EMILE SH, Horesh N, Garoufalia Z, Gefen R, et al
    Robotic and laparoscopic colectomy: propensity score-matched outcomes from a national cancer database.
    Br J Surg. 2023;110:717-726.
    PubMed     Abstract available
    
    
    
76. TEMMINK SJD, Peeters KCMJ, Bahadoer RR, Kranenbarg EM, et al
    Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD).
    Br J Surg. 2023;110:676-684.
    PubMed     Abstract available
    
    
    
77. BERTELSEN CA, Bianchi PP, Croner R, Kleif J, et al
    Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:734.
    PubMed    
    
    
    
78. SO JBY
    Bi-directional chemotherapy for peritoneal metastases.
    Br J Surg. 2023;110:627-628.
    PubMed    
    
    
    
79. CHONG Y, Perin G, Balasubramanian SP
    Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Br J Surg. 2023 May 8:znad122. doi: 10.1093.
    PubMed    
    
    
    April 2023
80. DOHRN N, Klein MF
    Colorectal cancer: current management and future perspectives.
    Br J Surg. 2023 Apr 20:znad095. doi: 10.1093.
    PubMed    
    
    
    
81. BENZ SR, Feder IS, Vollmer S, Tam Y, et al
    Author response to: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:621.
    PubMed    
    
    
    
82. BENZ SR, Feder IS, Vollmer S, Tam Y, et al
    Author response to: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:617.
    PubMed    
    
    
    
83. AKYOL C, Kuzu MA
    Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:614.
    PubMed    
    
    
    March 2023
84. CRIPPS P, Scott K, Sekhar H, Harries RL, et al
    Faecal immunochemical testing in symptomatic lower gastrointestinal triage: cohort study of patient acceptability and impact of social deprivation.
    Br J Surg. 2023;110:511-512.
    PubMed    
    
    
    
85. WANG X
    Comment on: Complete mesocolic excision for right colonic cancer: prospective multicentre study.
    Br J Surg. 2023;110:520.
    PubMed    
    
    
    
86. CASHIN PH, Soderstrom M, Blom K, Artursson S, et al
    Ex vivo assessment of chemotherapy sensitivity of colorectal cancer peritoneal metastases.
    Br J Surg. 2023 Mar 15:znad066. doi: 10.1093.
    PubMed    
    
    
    
87. 
    Erratum to: Outcomes of surgical resection in microsatellite instable colorectal cancer after immune checkpoint inhibitor treatment.
    Br J Surg. 2023 Mar 4:znad072. doi: 10.1093.
    PubMed    
    
    
    February 2023
88. WENSINK GE, Bolhuis K, Elferink MAG, Fijneman RJA, et al
    Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases.
    Br J Surg. 2023;110:362-371.
    PubMed     Abstract available
    
    
    
89. MATHEW A, Ramachandra D, Goyal A, Nariampalli Karthyarth M, et al
    Reconstructive techniques following low anterior resection for carcinoma of the rectum: meta-analysis.
    Br J Surg. 2023;110:313-323.
    PubMed     Abstract available
    
    
    
90. KITAGUCHI D, Hasegawa H, Teramura K, Ikeda K, et al
    Comparison of postoperative anorectal function between hand-sewn and stapled anastomoses in intersphincteric resection with transanal total mesorectal excision.
    Br J Surg. 2023;110:375-376.
    PubMed    
    
    
    
91. GERRARD AD, Maeda Y, Miller J, Gunn F, et al
    Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.
    Br J Surg. 2023 Feb 14:znad016. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. PEREA J, Winter D
    Early-onset sporadic colorectal cancer: key question of early diagnosis and screening strategies.
    Br J Surg. 2023 Feb 2:znad014. doi: 10.1093.
    PubMed    
    
    
    January 2023
93. EMILE SH, Horesh N, Freund MR, Garoufalia Z, et al
    Outcomes of laparoscopic versus robotic-assisted resection of T4 rectal cancer: propensity score-matched analysis of a national cancer database.
    Br J Surg. 2023;110:242-250.
    PubMed     Abstract available
    
    
    
94. SERRA-ARACIL X, Mora-Lopez L
    Author response to: Comment on: Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Br J Surg. 2023;110:284.
    PubMed    
    
    
    
95. ZHAO S, Tong W
    Comment on: Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Br J Surg. 2023;110:283.
    PubMed    
    
    
    
96. SERRA-ARACIL X, Zarate A, Bargallo J, Gonzalez A, et al
    Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.
    Br J Surg. 2023;110:150-158.
    PubMed     Abstract available
    
    
    
97. REUVERS JRD, Budding AE, van Egmond M, Stockmann HBAC, et al
    Gut Proteobacteria levels and colorectal surgical infections: SELECT trial.
    Br J Surg. 2023;110:129-132.
    PubMed    
    
    
    
98. 
    Erratum to: Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic.
    Br J Surg. 2023 Jan 4:znac459. doi: 10.1093.
    PubMed    
    
    
    December 2022
99. SHUKLA HS, Kumar S, Srivastava A
    Comment on: Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART).
    Br J Surg. 2022 Dec 15:znac441. doi: 10.1093.
    PubMed    
    
    
    
100. ALEXANDRE C, Medhi K, Christelle F, Thierry A, et al
     Outcomes of surgical resection in microsatellite instable colorectal cancer after immune checkpoint inhibitor treatment.
     Br J Surg. 2022 Dec 15:znac425. doi: 10.1093.
     PubMed    
     
     
     
101. BENZ SR, Feder IS, Vollmer S, Tam Y, et al
     Complete mesocolic excision for right colonic cancer: prospective multicentre study.
     Br J Surg. 2022;110:98-105.
     PubMed     Abstract available
     
     
     
102. CUSTERS PA, Geubels BM, Beets GL, Lambregts DMJ, et al
     Defining near-complete response following (chemo)radiotherapy for rectal cancer: systematic review.
     Br J Surg. 2022;110:43-49.
     PubMed     Abstract available
     
     
     
103. MAGHERBI H, Ouadi Y, Brahim MB, Boukriba S, et al
     Colonic lipoma.
     Br J Surg. 2022;110:122.
     PubMed    
     
     
     November 2022
104. STAIGER RD, Rossler F, Kim MJ, Brown C, et al
     Benchmarks in colorectal surgery: multinational study to define quality thresholds in high and low anterior resection.
     Br J Surg. 2022;109:1274-1281.
     PubMed     Abstract available
     
     
     
105. CONEFREY C, Ochieng C, Hoffman C, Elliott D, et al
     Managing surgical demand when needs outstrip resource: qualitative investigation of colorectal cancer surgery provision in the first wave of the COVID-19 pandemic.
     Br J Surg. 2022 Nov 7. pii: 6806207. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. 
     Corrigendum to: Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART).
     Br J Surg. 2022 Nov 3. pii: 6794309. doi: 10.1093.
     PubMed    
     
     
     October 2022
107. PANG K, Yang Y, Zhao P, Wu G, et al
     Adding immune checkpoint blockade to neoadjuvant chemoradiation in locally advanced rectal cancer.
     Br J Surg. 2022;109:1178-1179.
     PubMed    
     
     
     
108. BUETTNER S, Olthof PB, Wang J, Kreis ME, et al
     Author response to: Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
     Br J Surg. 2022;109:e122.
     PubMed    
     
     
     
109. LIU QL, Chen HN
     Comment on: KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
     Br J Surg. 2022;109:e121.
     PubMed    
     
     
     
110. FAHIM M, Couwenberg A, Verweij ME, Dijksman LM, et al
     SPONGE-assisted versus Trendelenburg position surgery in laparoscopic sigmoid and rectal cancer surgery (SPONGE trial): randomized clinical trial.
     Br J Surg. 2022;109:1081-1086.
     PubMed     Abstract available
     
     
     
111. BISSET CN, Ferguson E, MacDermid E, Stein SL, et al
     Exploring variation in surgical practice: does surgeon personality influence anastomotic decision-making?
     Br J Surg. 2022;109:1156-1163.
     PubMed     Abstract available
     
     
     September 2022
112. LAMAZZA A, Fiori E, Carati M, Antoniozzi A, et al
     Endoscopic stenting for left-sided obstructing colorectal cancer.
     Br J Surg. 2022 Sep 27. pii: 6718181. doi: 10.1093.
     PubMed    
     
     
     
113. DACA-ALVAREZ M, Marti M, Spinelli A, de Miranda NFFC, et al
     Familial component of early-onset colorectal cancer: opportunity for prevention.
     Br J Surg. 2022 Sep 15. pii: 6701677. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. FERNANDEZ B, Fleming CA, Marichez A, Mauriac P, et al
     Advances in pelvic exenteration surgery can support clear margin resection for metastatic non-pelvic primary malignancies.
     Br J Surg. 2022;109:1023-1024.
     PubMed    
     
     
     
115. DAY NM, Kearsey CC, Sutton PA
     Neoadjuvant treatment of advanced colonic cancer: a paradigm shift?
     Br J Surg. 2022;109:895-897.
     PubMed    
     
     
     
116. YEOW M, Soh S, Wong J, Koh FH, et al
     Transanal tube versus defunctioning stoma after low anterior resection for rectal cancer: network meta-analysis of randomized controlled trials.
     Br J Surg. 2022;109:900-903.
     PubMed    
     
     
     
117. KIYOZUMI Y, Akiyoshi T, Mukai T, Hiyoshi Y, et al
     Lateral local recurrence after total mesorectal excision for mid/low rectal cancer: study of clinical characteristics and impact of salvage surgery on survival.
     Br J Surg. 2022;109:904-907.
     PubMed    
     
     
     
118. MAROLI A, Carvello M, Foppa C, Kraft M, et al
     Anxiety as a risk factor for postoperative complications after colorectal surgery: new area for perioperative optimization.
     Br J Surg. 2022;109:898-899.
     PubMed    
     
     
     August 2022
119. KUNITOMO A, Ouchi A, Matsuo K, Komori K, et al
     Clinical significance of surgical intervention for isolated para-aortic lymph node metastasis from colorectal cancer: a time-varying co-variate analysis.
     Br J Surg. 2022 Aug 30. pii: 6678830. doi: 10.1093.
     PubMed    
     
     
     
120. 
     Colorectal Endoscopic Stenting Trial (CReST) for obstructing left-sided colorectal cancer: randomized clinical trial.
     Br J Surg. 2022 Aug 20. pii: 6672717. doi: 10.1093.
     PubMed     Abstract available
     
     
     
121. ANDERSEN BT, Kazaryan AM, Stimec BV, Edwin B, et al
     Personalized surgery for the splenic flexure cancer: new frontiers.
     Br J Surg. 2022;109:880-881.
     PubMed    
     
     
     
122. OLTHOF PB, Buettner S, Andreatos N, Wang J, et al
     KRAS alterations in colorectal liver metastases: shifting to exon, codon, and point mutations.
     Br J Surg. 2022;109:804-807.
     PubMed    
     
     
     
123. 
     Incisional hernia following colorectal cancer surgery according to suture technique: Hughes Abdominal Repair Randomized Trial (HART).
     Br J Surg. 2022 Aug 8. pii: 6656065. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2022
124. SIJBERDEN JP, Abu Hilal M
     Comment on: Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
     Br J Surg. 2022 Jul 16. pii: 6645296. doi: 10.1093.
     PubMed    
     
     
     
125. GEORGE AJ, Thomas C, Mathew DE, Jesudasan MR, et al
     Viral RNA in peritoneal, rectal, and blood samples from surgical patients with COVID-19.
     Br J Surg. 2022;109:772.
     PubMed    
     
     
     
126. FLEMING C, Vendrely V, Rullier E, Denost Q, et al
     Organ preservation in rectal cancer: review of contemporary management.
     Br J Surg. 2022;109:695-703.
     PubMed     Abstract available
     
     
     
127. PODDA M, Pisanu A, Di Saverio S
     Author response to: Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
     Br J Surg. 2022;109:e96.
     PubMed    
     
     
     
128. WANG X, Zheng Z, Xie Z, Huang S, et al
     Comment on: Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
     Br J Surg. 2022;109:e95.
     PubMed    
     
     
     
129. MORISSON L, Verdonck O, Latulippe JF, Richebe P, et al
     Comment on: Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial.
     Br J Surg. 2022;109:e93.
     PubMed    
     
     
     
130. FRANDON J, Berny L, Prudhomme M, de Forges H, et al
     Inferior mesenteric artery embolization ahead of rectal cancer surgery: AMIREMBOL pilot study.
     Br J Surg. 2022;109:650-652.
     PubMed    
     
     
     June 2022
131. 
     Impact of microsatellite status in early-onset colonic cancer.
     Br J Surg. 2022;109:632-636.
     PubMed     Abstract available
     
     
     
132. NORDKAMP S, Voogt ELK, van Zoggel DMGI, Martling A, et al
     Locally recurrent rectal cancer: oncological outcomes with different treatment strategies in two tertiary referral units.
     Br J Surg. 2022;109:623-631.
     PubMed     Abstract available
     
     
     
133. ROSEN R, Nilsson E, Rahman M, Ronnow CF, et al
     Accuracy of MRI in early rectal cancer: national cohort study.
     Br J Surg. 2022;109:570-572.
     PubMed    
     
     
     May 2022
134. YAQUB S
     Comment on: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
     Br J Surg. 2022 May 17. pii: 6587119. doi: 10.1093.
     PubMed    
     
     
     
135. SIRIWARDENA AK
     Author response to: Synchronous resection of primary colorectal cancer with liver metastases: Two birds with one stone?
     Br J Surg. 2022 May 17. pii: 6586615. doi: 10.1093.
     PubMed    
     
     
     
136. BJORNELV GMW, Zolic-Karlsson Z, Dueland S, Line PD, et al
     Cost-effectiveness of liver transplantation versus last-resort systemic therapy for colorectal liver metastases.
     Br J Surg. 2022;109:483-485.
     PubMed    
     
     
     
137. KOTHARI A, White MG, Peacock O, Kaur H, et al
     Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer.
     Br J Surg. 2022;109:489-492.
     PubMed    
     
     
     April 2022
138. VIGANO L, Terrone A, Costa G, Franchi E, et al
     Effect of chemotherapy on tumour-vessel relationship in colorectal liver metastases.
     Br J Surg. 2022;109:401-404.
     PubMed    
     
     
     
139. VAN DER HEIJDEN JAG, Qaderi SM, Verhoeven R, Custers JAE, et al
     Author response to: Transanal total mesorectal excision and low anterior resection syndrome.
     Br J Surg. 2022;109:e78.
     PubMed    
     
     
     
140. WALKER ET, McDermott FD, Smart NJ, Daniels IR, et al
     Comment on: Transanal total mesorectal excision and low anterior resection syndrome.
     Br J Surg. 2022;109:e77.
     PubMed    
     
     
     
141. KOTHARI A, White MG, Peacock O, Kaur H, et al
     Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer.
     Br J Surg. 2022 Apr 4. pii: 6562962. doi: 10.1093.
     PubMed    
     
     
     March 2022
142. SAW KS, Liu C, Xu W, Varghese C, et al
     Corrigendum to: Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
     Br J Surg. 2022 Mar 15. pii: 6548412. doi: 10.1093.
     PubMed    
     
     
     
143. PODDA M, Pisanu A, Morello A, Segalini E, et al
     Laparoscopic versus open colectomy for locally advanced T4 colonic cancer: meta-analysis of clinical and oncological outcomes.
     Br J Surg. 2022;109:319-331.
     PubMed     Abstract available
     
     
     
144. ZWANENBURG ES, Wisselink DD, Klaver CEL, Brandt ARM, et al
     Adhesion formation after surgery for locally advanced colonic cancer in the COLOPEC trial.
     Br J Surg. 2022;109:315-318.
     PubMed    
     
     
     
145. LOKUHETTY N, Mohan HM, Kong JC, Heriot AG, et al
     Lateral pelvic sidewall dissection in rectal cancer: case selection and training to optimize outcomes.
     Br J Surg. 2022;109:306-307.
     PubMed    
     
     
     February 2022
146. PATEL A, Spychalski P, Kobiela J
     Short-course radiotherapy and consolidation chemotherapy: in search of a balanced protocol.
     Br J Surg. 2022;109:e50-e51.
     PubMed    
     
     
     
147. 
     Microsatellite instability in young patients with rectal cancer: molecular findings and treatment response.
     Br J Surg. 2022;109:251-255.
     PubMed    
     
     
     
148. SOREIDE K
     Time to halt perioperative chemotherapy for resectable colorectal liver metastasis?
     Br J Surg. 2022;109:242-243.
     PubMed    
     
     
     
149. CAMERON D, Talari A, Rehman I, Mitchell P, et al
     Detecting colorectal cancer using infrared spectroscopy.
     Br J Surg. 2022 Feb 10. pii: 6525757. doi: 10.1093.
     PubMed    
     
     
     
150. CRISTAUDO AT, Morris DL
     Hypothesis to explain the disparity in the proportion of liver metastases between appendiceal and colorectal cancer.
     Br J Surg. 2022 Feb 8. pii: 6524033. doi: 10.1093.
     PubMed    
     
     
     
151. SIRIWARDENA AK
     Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?
     Br J Surg. 2022 Feb 3. pii: 6521658. doi: 10.1093.
     PubMed    
     
     
     
152. BRADLEY A, Knight S, Chin MY, Moug S, et al
     Comment on: Permanent stoma rates after anterior resection for rectal cancer: risk prediction scoring using preoperative variables.
     Br J Surg. 2022;109:e39.
     PubMed    
     
     
     
153. BACK E, Haggstrom J, Holmgren K, Haapamaki MM, et al
     Author response to: Permanent stoma prediction after anterior resection for rectal cancer: risk prediction scoring using preoperative variables.
     Br J Surg. 2022;109:e40.
     PubMed    
     
     
     
154. VAN DEN HEEDE K, Chidambaram S, Van Slycke S, Brusselaers N, et al
     Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
     Br J Surg. 2022;109:191-199.
     PubMed     Abstract available
     
     
     December 2021
155. JUNG F, Lee M, Doshi S, Zhao G, et al
     Neoadjuvant therapy versus direct to surgery for T4 colon cancer: meta-analysis.
     Br J Surg. 2021;109:30-36.
     PubMed     Abstract available
     
     
     
156. DENG X, Wu Q, Bi L, Yu Y, et al
     Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial.
     Br J Surg. 2021;109:121-128.
     PubMed     Abstract available
     
     
     
157. BAHADOER RR, Peeters KCMJ, Beets GL, Figueiredo NL, et al
     Watch and wait after a clinical complete response in rectal cancer patients younger than 50 years.
     Br J Surg. 2021;109:114-120.
     PubMed     Abstract available
     
     
     
158. RAJARETNAM N, Smart NJ
     To mesh or not to mesh-the known unknowns of preventing parastomal hernias.
     Br J Surg. 2021;109:1-2.
     PubMed    
     
     
     
159. SAW KS, Liu C, Xu W, Varghese C, et al
     Faecal immunochemical test to triage patients with possible colorectal cancer symptoms: meta-analysis.
     Br J Surg. 2021 Dec 15. pii: 6462011. doi: 10.1093.
     PubMed     Abstract available
     
     
     
160. DUELAND S, Syversveen T, Hagness M, Grut H, et al
     Liver transplantation for advanced liver-only colorectal metastases.
     Br J Surg. 2021;108:1402-1405.
     PubMed    
     
     
     November 2021
161. POLSON R, Abdelqader B, Chung WY, Sangal S, et al
     Impact of the COVID-19 pandemic on early outcomes after colorectal cancer surgery.
     Br J Surg. 2021 Nov 11. pii: 6425606. doi: 10.1093.
     PubMed    
     
     
     
162. CLIFFORD RE, Harji D, Poynter L, Jackson R, et al
     Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study.
     Br J Surg. 2021;108:1270-1273.
     PubMed    
     
     
     
163. VAN HERWAARDEN YJ, Madani A, van der Post RS, Lemmens VEPP, et al
     Incidental diagnosis of serrated polyp in the appendix warrants colonoscopy to screen for colorectal neoplasia.
     Br J Surg. 2021;108:e373-e374.
     PubMed    
     
     
     
164. BACK E, Haggstrom J, Holmgren K, Haapamaki MM, et al
     Permanent stoma rates after anterior resection for rectal cancer: risk prediction scoring using preoperative variables.
     Br J Surg. 2021;108:1388-1395.
     PubMed     Abstract available
     
     
     
165. HOL JC, Burghgraef TA, Rutgers MLW, Crolla RMPH, et al
     Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer: a retrospective propensity score-matched cohort study of short-term outcomes.
     Br J Surg. 2021;108:1380-1387.
     PubMed     Abstract available
     
     
     October 2021
166. KANANI A, Veen T, Soreide K
     Neoadjuvant immunotherapy in primary and metastatic colorectal cancer.
     Br J Surg. 2021 Oct 25. pii: 6409933. doi: 10.1093.
     PubMed     Abstract available
     
     
     
167. PERDAWOOD SK, Neufert RS, Kroeigaard J, Maina PJ, et al
     Low presence of intraluminal cancer cells in rectal washout during transanal total mesorectal excision.
     Br J Surg. 2021;108:e338-e339.
     PubMed    
     
     
     
168. TIBERMACINE H, Rouanet P, Sbarra M, Forghani R, et al
     Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches.
     Br J Surg. 2021;108:1243-1250.
     PubMed     Abstract available
     
     
     
169. HAAK HE, Beets GL, Peeters K, Nelemans PJ, et al
     Prevalence of nodal involvement in rectal cancer after chemoradiotherapy.
     Br J Surg. 2021;108:1251-1258.
     PubMed     Abstract available
     
     
     
170. POLSON R, Abdelqadar B, Chung WY, Sangal S, et al
     Impact of the COVID-19 pandemic on early outcomes after colorectal cancer surgery.
     Br J Surg. 2021 Oct 21. pii: 6406949. doi: 10.1093.
     PubMed    
     
     
     
171. ISMAIEL M, Murphy B, Hayes C, O'Connell LV, et al
     Differential inflammatory profile of mesenteric and omental fat in patients with colorectal cancer.
     Br J Surg. 2021 Oct 6. pii: 6382002. doi: 10.1093.
     PubMed    
     
     
     
172. DIAMANTIS A, Samara AAlpha, Tzovaras G, Magouliotis D, et al
     Use of preoperative EORTC quality-of-life questionnaires to predict postoperative complications after colorectal cancer surgery.
     Br J Surg. 2021 Oct 3. pii: 6380642. doi: 10.1093.
     PubMed    
     
     
     September 2021
173. ASHRAF H, Anderson RG, Anderson DJ, Moug SJ, et al
     Feasibility of a perioperative smartphone application in colorectal surgery.
     Br J Surg. 2021;108:e282-e283.
     PubMed    
     
     
     
174. MORINO M, Forcignano E, Arezzo A
     Early clinical adoption of a flexible robotic endoscope for local excision of rectal lesions.
     Br J Surg. 2021;108:e296.
     PubMed    
     
     
     August 2021
175. SOLOMON MJ, Daster S, Loizides S, Sutton P, et al
     Access to the anterior pelvic compartment in pelvic exenteration in women-the interlabial approach: video vignette.
     Br J Surg. 2021;108:e268-e269.
     PubMed    
     
     
     
176. SUTTON PA, Solomon M, Sasidharan P, Lee P, et al
     Abdominolithotomy sacrectomy for the management of locally recurrent rectal cancer: video vignette.
     Br J Surg. 2021;108:e257.
     PubMed    
     
     
     
177. WALDRON RM, Moloney BM, Gilligan K, Lowery AJ, et al
     MicroRNAs as biomarkers of multimodal treatment for rectal cancer.
     Br J Surg. 2021;108:e260-e261.
     PubMed    
     
     
     
178. EL-WAJEH YAM, Askari G, Gordji ME, Mohammed-Ali RI, et al
     Elementary introduction to game theory, rationality and hyper-rationality decision-making: optimizing a surgeon's negotiation strategies.
     Br J Surg. 2021;108:e262-e263.
     PubMed    
     
     
     
179. VAN DER HEIJDEN JAG, Qaderi SM, Verhoeven R, Custers JAE, et al
     Transanal total mesorectal excision and low anterior resection syndrome.
     Br J Surg. 2021;108:991-997.
     PubMed     Abstract available
     
     
     
180. KAWAGUCHI Y, Kopetz S, Tran Cao HS, Panettieri E, et al
     Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.
     Br J Surg. 2021;108:968-975.
     PubMed     Abstract available
     
     
     
181. LEE J, Grubac V, Baxter N, Auer R, et al
     Digital rectal examination in palpable rectal cancer: expert panel consensus on key elements and analysis of a case series.
     Br J Surg. 2021;108:e264-e265.
     PubMed    
     
     
     
182. CELARIER S, Monziols S, Celerier B, Assenat V, et al
     Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS trial): a phase III randomized controlled trial.
     Br J Surg. 2021;108:998-1005.
     PubMed     Abstract available
     
     
     July 2021
183. ROXBURGH CS
     Organ preservation in rectal cancer: towards the norm rather than the exception.
     Br J Surg. 2021;108:745-747.
     PubMed    
     
     
     
184. DE LA MOTTE L, Custovic S, Tapper J, Arver S, et al
     Effect of preoperative radiotherapy for rectal cancer on spermatogenesis.
     Br J Surg. 2021;108:750-753.
     PubMed    
     
     
     
185. D'SOUZA N, Delisle TG, Chen M, Benton SC, et al
     Faecal immunochemical testing in symptomatic patients to prioritize investigation: diagnostic accuracy from NICE FIT Study.
     Br J Surg. 2021;108:804-810.
     PubMed     Abstract available
     
     
     
186. ISONIEMI H, Uutela A, Nordin A, Lantto E, et al
     Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
     Br J Surg. 2021;108:817-825.
     PubMed     Abstract available
     
     
     June 2021
187. RYOO SB, Park JW, Lee DW, Lee MA, et al
     Anterior resection syndrome: a randomized clinical trial of a 5-HT3 receptor antagonist (ramosetron) in male patients with rectal cancer.
     Br J Surg. 2021;108:644-651.
     PubMed     Abstract available
     
     
     
188. DENOST Q, Rouanet P, Faucheron JL, Panis Y, et al
     Impact of early biochemical diagnosis of anastomotic leakage after rectal cancer surgery: long-term results from GRECCAR 5 trial.
     Br J Surg. 2021;108:605-608.
     PubMed    
     
     
     
189. TALBOOM K, Vogel I, Blok RD, Roodbeen SX, et al
     Highly selective diversion with proactive leakage management after low anterior resection for rectal cancer.
     Br J Surg. 2021;108:609-612.
     PubMed    
     
     
     
190. VOOGT ELK, Nordkamp S, Nieuwenhuijzen GAP, Creemers GJ, et al
     Curative treatment of locally recurrent rectal cancer: is induction chemotherapy warranted?
     Br J Surg. 2021;108:e213-e214.
     PubMed    
     
     
     May 2021
191. SEPPALA TT, Latchford A, Negoi I, Sampaio Soares A, et al
     European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender.
     Br J Surg. 2021;108:484-498.
     PubMed     Abstract available
     
     
     
192. GRAVERSEN M, Detlefsen S, Pfeiffer P, B Mortensen M, et al
     Local peritoneal toxicity from adjuvant pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in high-risk patients with colonic cancer.
     Br J Surg. 2021;108:e187-e188.
     PubMed    
     
     
     
193. CREAVIN B, Kelly ME, Ryan EJ, Ryan OK, et al
     Oncological outcomes of laparoscopic versus open rectal cancer resections: meta-analysis of randomized clinical trials.
     Br J Surg. 2021;108:469-476.
     PubMed     Abstract available
     
     
     
194. CHAKRABARTI D, Rajan S, Akhtar N, Qayoom S, et al
     Short-course radiotherapy with consolidation chemotherapy versus conventionally fractionated long-course chemoradiotherapy for locally advanced rectal cancer: randomized clinical trial.
     Br J Surg. 2021;108:511-520.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.